Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Hospital Clínico de la Universidad de Chile, Independencia, Santiago, Chile
Lindesberg Hospital, Lindesberg, Region Örebro, Sweden
Sahlgrenska University hospital/ Östra hopsital, Gothenburg, VG, Sweden
UMC Ljubljana, Ljubljana, Slovenia
Shanghai Ninth People's Hospital , Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
West China Hospital,Sichuan University, Chengdu, China
University of South Florida, Tampa, Florida, United States
Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation
Saint Petersburg State University Hospital, Saint Petersburg, Russian Federation
Meshalkin Research Institute of Pathology of Circulation, Novosibirsk, Russian Federation
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Shanghai Fengxian District Central Hospital, Shanghai, China
West China Hospital, Sichuan University, Changde, China
The Third Xiangya Hospital of Central South University, Changsha, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.